Literature DB >> 6050811

Primary aldosteronism with suppressed plasma renin activity due to bilateral nodular adrenocortical hyperplasia.

F H Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6050811     DOI： 10.7326/0003-4819-67-5-1035

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.

Authors:  H Vetter; W Vetter
Journal:  Klin Wochenschr       Date:  1975-04-15

2.  [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].

Authors:  A Helber; K A Meurer; E Rosskamp; G Wambach; H A Dickmans; W Kaufmann
Journal:  Klin Wochenschr       Date:  1974-10-15

Review 3.  [Hypermineralocorticoidism and hypertension].

Authors:  H P Wolff; S Abdelhamid
Journal:  Klin Wochenschr       Date:  1971-03-15

4.  [Hypertension and aldosteronism in solitary adenomas and nodular hyperplasia of the adrenal cortex].

Authors:  A Distler; C Barth; S Roscher; P Vecsei; G Dhom; H P Wolff
Journal:  Klin Wochenschr       Date:  1969-07-01

5.  Non-tumorous "primary" aldosteronism: II. Type not relieved by glucocorticoid.

Authors:  I S Salti; J L Ruse; M Stiefel; N C Delarue; J C Laidlaw
Journal:  Can Med Assoc J       Date:  1969-07-12       Impact factor: 8.262

6.  Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.

Authors:  J B Ferriss; J J Brown; R Fraser; E Haywood; D L Davies; A W Kay; A F Lever; J I Robertson; K Owen; W S Peart
Journal:  Br Med J       Date:  1975-01-18

7.  Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.

Authors:  David C Kem; Hongliang Li; Carolina Velarde-Miranda; Campbell Liles; Megan Vanderlinde-Wood; Allison Galloway; Muneer Khan; Caitlin Zillner; Alexandria Benbrook; Veitla Rao; Celso E Gomez-Sanchez; Madeleine W Cunningham; Xichun Yu
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

8.  Primary aldosteronism and malignant adrenocortical neoplasia.

Authors:  T M Salassa; R E Weeks; R C Northcutt; J A Carney
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

9.  Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.

Authors:  Kei Omata; Fumitoshi Satoh; Ryo Morimoto; Sadayoshi Ito; Yuto Yamazaki; Yasuhiro Nakamura; Sharath K Anand; Zeng Guo; Michael Stowasser; Hironobu Sasano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

10.  Evolution of the surgical management of primary aldosteronism.

Authors:  S P Auda; M F Brennan; J R Gill
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.